Public Plans
Public plans are plans created using the DMP Tool service and shared publicly by their owners. They are not vetted for quality, completeness, or adherence to funder guidelines.
Plans (79)
NIH-Default DMSP
Pre-frontal tDCS as a novel intervention to reduce effects of post-stroke fatigue while improving language and attention in aphasia
Ellyn Riley, Syracuse University (syr.edu)
NIH-Default DMSP
Spreading depolarizations initiated by hypoxic-ischemic injury signal risk for brain death
Jesse Skoch, Cincinnati Children's Hospital Medical Center (cincinnatichildrens.org)
NIH-Default DMSP
Optimizing implementation of long-acting injectable PrEP
Steven John, Medical College of Wisconsin (mcw.edu)
NIH-Default DMSP
Innovative Deep Phenotyping of African Americans at Risk for Alzheimer’s disease
David Loewenstein, University of Miami (miami.edu)
NIH-Default DMSP
Exploration and Validation of SHIPi Approaches in Models of Alzheimer’s Disease
William Kerr, SUNY Upstate Medical University (upstate.edu)
NIH-Default DMSP
Heterogeneity in function of parenchymal and airway neutrophils during pneumonia induced by S. pneumoniae
Claire Doerschuk, University of North Carolina School of Medicine (med.unc.edu)
NIH-Default DMSP
The role of NIK in cytosolic DNA sensing pathways
Kislay Parvatiyar, Tulane University (tulane.edu)
NIH-Default DMSP
A non-canonical IRAK1 signaling pathway triggered by ionizing radiation
Samuel Sidi, Icahn School of Medicine at Mount Sinai (icahn.mssm.edu)
NIH-Default DMSP
Neurodevelopmental effects of embryonic exposure to psychotropic medications in real-world mixtures
Dena Weinberger, Murray State University (murraystate.edu)
NIH-Default DMSP
Targeting Hepatic Mitochondrial Oxidation to Treat NAFLD, NASH and T2D
Gerald Shulman, Yale University (yale.edu)
